E6742

· Eisai Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for E6742, covering 2023-09-29 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study of E6742 in Participants With Systemic Lupus Erythematosus [Phase 2]